Janice Newberry

About

With 15 years in the oncology pharmaceuticals sector, my journey reflects a commitment to advancing cancer treatment and patient care. Currently at BI, my mission is pioneering targeted therapies while fostering collaborations. My expertise in pharmaceutical marketing and strategic KOL advocacy has become a cornerstone of my approach, ensuring that diverse insights catalyze innovation within the oncology community. At Daiichi Sankyo, I was instrumental in the foundational RML Team for DSI Oncology, propelling the regional marketing of key ADC assets in various cancer types. My role encompassed everything from KOL segmenting and speakers bureau management to congress planning and vendor partnerships, leveraging skills in active listening and new business development to drive forward our oncology portfolio. These experiences have honed my capacity to navigate complex market dynamics and deliver impactful strategies within the oncology sphere. My previous experience includes national launches of targeted therapies, immunotherapies and antibody drug conjugates marketing in both the pre commercial and FDA approved spaces. The most difficult thing is the decision to act, the rest is merely tenacity. -Amelia Earhart

Experience

• Senior Thoracic Consultant · Boehringer Ingelheim08-01-2024

  Pre commercial HER2 TKI NSCLC BiTE anti-DLL3/CD3 T cell engager SCLC Oncylytic virus P1.

• Associate Director, Regional Marketing · Daiichi Sankyo, Inc.09-01-2022 – 11-01-2024

  Founding member RML Team DSI Oncology. Regional Marketing for ADC Assets: Enhertu HER2-DXd, Dato-DXd Trop-2, Patritumab Deructecan HER3-DXd in GU GI MBC & NSCLC and HER-2 solid tumors. HCP Marketing: KOL segmenting, speakers bureau management and expansion, Ad boards, KOL consultant recruitment and contracting, congress planning, brand insights, events and marketing projects, cme content. Vendor partnerships with Ideology Health, Onc Live, MJH Life Sciences etc. Society partnership. 2023 RML ASCO Lead Oncology. KOL Advocacy in accounts that include: Northwestern, Mayo Clinic, Michigan, Chicago, Cleveland Clinic, Karmanos, Henry Ford, Siteman Cancer Center, UAB, Colorado, Wisconsin, Indiana, Kansas, US Oncology (Minnesota Oncology, Rocky Mountain Cancer, Texas Oncology), Rush, Nebraska Medicine, Iowa, Tulane, Oschner LSU, Mary Bird Perkins, New Orleans Med Center, Oklahoma.

• Associate Director, Thought Leader Liaison · Sanofi Genzyme01-01-2018 – 09-01-2022

  Established and managed NSCLC and Skin Cancer Speakers bureau, recruiting KOLs for oncology assets, and organizing Congress strategy. HCP Marketing strategy and project management. Collaborated with internal and external stakeholders for insights generation and advisory boards. Advocated for KOLs in top accounts like Stanford, UCLA, and Mayo Clinics.

• Senior Oncology Specialist · Eisai US09-01-2016 – 01-01-2018

  Breast Cancer, Soft Tissue Sarcoma and Renal Cancer. Chemotherapy and Chemo/IO combination. 4 State Geography: CO UT NM WY. Key Accounts: UNM, Huntsman, University of Colorado, Rocky Mountain Cancer Centers, Intermountain Health, SCL, Banner MD Anderson.

• Senior Oncology Sales Specialist · Bristol Myers Squibb01-01-2014 – 09-01-2016

  National launch CTLA 4 and PD1 Immuno therapies in Lung, Melanoma, Renal and NHL. Top 15% Yervoy sales individual contributor. KOLs University of Colorado Cutaneous and Thoracic Clinics and KOLs USO/McKesson. 5 State Rockies geography in North Central Region.

Education

• Michigan State UniversityBachelor's degree, Business Administration and Management, General

Similar talent on Pangea

Ben B.Senior Marketing Manager Driving Strategic Market Development in HealthcareSeattle, WAChristina F.Pharma & Health Tech | Omnichannel HCP Engagement | Digital Ecosystems | Editorial Ops | Regulated CommsNew York, NYRobin M.Healthcare Product Marketing & Sales Enablement Leader | Go-to-Market Strategy | Cross-Functional ExecutionFlorida, USAKristen F.Marketing Leader in Pharmaceutical & Medical Device Industry | Expertise in Brand Growth, Project Management, & Cross-Functional CollaborationUnited States